Cyanotech Corp stock (US2324373016): niche algae producer navigates headwinds after Nasdaq delisting

Cyanotech Corp, a Hawaii-based producer of microalgae ingredients, continues to operate in a niche market after its recent Nasdaq delisting and ongoing financial pressures. We outline the business model, key revenue drivers and context for US investors.

Cyanotech Corp, a producer of natural astaxanthin and spirulina products from microalgae, remains on the radar of some US micro-cap investors despite recent setbacks, including financial losses and the loss of its Nasdaq listing in early 2024, according to a delisting notice from Nasdaq dated January 2024 and company disclosures referenced by outlets such as MarketWatch as of 02/02/2024.Nasdaq as of 02/02/2024 and MarketWatch as of 03/15/2024.

In its most recently available annual filing for the fiscal year ended March 31, 2024, published in mid-2024, Cyanotech reported continued operating losses, reflecting pressure from higher input costs and competitive pricing in dietary supplements, according to the company’s Form 10-K filed with the SEC.SEC filing as of 07/01/2024

As of: 05/18/2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Cyanotech Corp
• Sector/industry: Nutritional supplements / specialty ingredients
• Headquarters/country: Kailua-Kona, Hawaii, United States
• Core markets: Nutraceuticals, dietary supplements, functional foods
• Key revenue drivers: Natural astaxanthin and spirulina products
• Home exchange/listing venue: Formerly Nasdaq Capital Market (ticker: CYAN); currently quoted on US OTC markets
• Trading currency: US dollar (USD)

Cyanotech Corp: core business model

Cyanotech Corp focuses on cultivating microalgae in open ponds at its facility near Kona, Hawaii, using abundant sunlight and deep ocean water to grow biomass that is processed into branded ingredients. The company’s business centers on two main product lines: BioAstin, a natural astaxanthin ingredient used for antioxidant support, and Hawaiian Spirulina, a protein- and nutrient-rich algae powder for supplements and foods, according to company product descriptions published on its website.Cyanotech website as of 11/15/2024

The group sells finished consumer products under its own brands as well as bulk ingredients to private-label manufacturers and food and beverage companies. This dual-channel model allows Cyanotech to capture value both as a branded supplement provider and as a business-to-business supplier, but it also exposes the company to competition from larger nutraceutical firms and low-cost producers in markets such as Asia, according to the risk factors outlined in its annual report for fiscal 2024.SEC filing as of 07/01/2024

Production is concentrated at a single site in Hawaii, which gives Cyanotech access to a stable climate but also concentrates operational risks such as weather events and local regulatory requirements. The company highlights the use of deep ocean water and renewable resources as part of its sustainability positioning, aiming to appeal to environmentally conscious consumers and brand owners that seek natural, non-synthetic ingredients in their formulations, according to statements in its corporate responsibility materials and marketing descriptions.Cyanotech sustainability overview as of 10/10/2024

Main revenue and product drivers for Cyanotech Corp

Revenue at Cyanotech is primarily generated from sales of astaxanthin and spirulina ingredients and finished products into the US and selected international markets. In fiscal 2024, the company reported that astaxanthin products represented the larger share of net sales compared with spirulina, reflecting higher pricing per unit due to the specialized nature of the carotenoid and its use in premium dietary supplements, according to its Form 10-K for the year ended March 31, 2024.SEC filing as of 07/01/2024

The company’s BioAstin line is marketed for applications such as joint health, eye health and skin support, while Hawaiian Spirulina is often positioned as a superfood ingredient for smoothies, tablets and nutritional bars. Distribution channels include health food retailers, online platforms and direct shipments to contract manufacturers. Cyanotech’s performance is therefore closely linked to consumer demand for natural supplements, retail trends in specialty nutrition stores and its ability to secure shelf space and digital visibility in a crowded marketplace, according to its management discussion in the fiscal 2024 annual report.SEC MD&A as of 07/01/2024

Volume and pricing are influenced by harvest yields, cultivation efficiency and production costs for energy, nutrients and labor at the Kona facility. Any disruptions in pond operations, contamination events or adverse weather can affect biomass output and, by extension, sales volumes. At the same time, wholesale prices for algae-based ingredients can fluctuate based on industry supply-demand dynamics and competition from synthetic astaxanthin or alternative plant-based antioxidants, according to industry commentary reported by nutrition trade media in 2023 and 2024.Nutritional Outlook as of 09/21/2023

Industry trends and competitive position

The global market for algae-derived ingredients has expanded in recent years as consumers and manufacturers look for natural alternatives to synthetic additives. Reports from market research providers suggest that demand for microalgae-based nutraceuticals and pigments, including spirulina and astaxanthin, is expected to grow steadily through the decade, driven by interest in plant-based diets and functional foods, according to a 2023 overview by Grand View Research.Grand View Research as of 06/20/2023

Within this setting, Cyanotech competes with both regional and international players. Larger ingredient suppliers may benefit from greater economies of scale, diversified product portfolios and access to capital, while some Asian producers compete aggressively on price. Cyanotech differentiates itself by emphasizing Hawaiian origin, natural cultivation methods and vertically integrated operations, but the company’s relatively small size and concentration in two product categories can make it more vulnerable to market swings and regulatory shifts, as highlighted in its fiscal 2024 risk disclosures.SEC risk factors as of 07/01/2024

Regulation is another important factor. In the United States, dietary supplements are regulated under a framework that requires manufacturers to ensure product safety and labeling accuracy, while certain health claims are restricted. Cyanotech notes that changes in regulatory interpretation by agencies such as the FDA could require label modifications, additional testing or reformulation, potentially affecting costs and time-to-market for new products, according to its latest annual report.SEC filing as of 07/01/2024

Why Cyanotech Corp matters for US investors

For US investors, Cyanotech represents a micro-cap company tied to structural themes such as natural ingredients, plant-based nutrition and sustainable production methods. Its operations are based entirely in the United States, and its products are sold to domestic supplement brands and retailers, meaning performance is closely linked to US consumer spending on health and wellness and to trends in specialty retail and e-commerce.

The delisting from the Nasdaq Capital Market has shifted trading into the over-the-counter space, which typically features lower liquidity and higher volatility compared with major exchanges. This change can have implications for bid-ask spreads and execution quality for investors. Nonetheless, Cyanotech continues to publish SEC filings and maintain investor communications through its website, providing ongoing transparency about its operations, financial condition and strategic initiatives.

Conclusion

Cyanotech Corp operates in a narrow but growing corner of the nutrition industry, supplying algae-derived ingredients such as astaxanthin and spirulina from its Hawaii facility. The company’s concentration in two product categories, single-site production and micro-cap scale contribute to operational and financial risk, which has been reflected in recent losses and its transition from Nasdaq to OTC trading. At the same time, structural demand for natural supplements and functional foods provides a supportive backdrop for its core markets, and ongoing SEC reporting offers investors insight into how management addresses cost pressures, competition and regulatory requirements over time.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.